Authors:
SJ Vervoort, OG de Jong, MG Roukens, CL Frederiks, JF Vermeulen, AR Lourenço, L Bella, AT Vidakovic, JL Sandoval, C Moelans, M van Amersfoort, MJ Dallman, A Bruna, C Caldas, E Nieuwenhuis, E van der Wall, P Derksen, P van Diest, MC Verhaar, EW-F Lam, M Mokry, PJ Coffer
Journal name: 
Elife
Citation info: 
Vol. 7
Abstract: 
The expression of the transcription factor SOX4 is increased in many human cancers, however, the pro-oncogenic capacity of SOX4 can vary greatly depending on the type of tumor. Both the contextual nature and the mechanisms underlying the pro-oncogenic SOX4 response remain unexplored. Here, we demonstrate that in mammary tumorigenesis, the SOX4 transcriptional network is dictated by the epigenome and is enriched for pro-angiogenic processes. We show that SOX4 directly regulates endothelin-1 (ET-1) expression and can thereby promote tumor-induced angiogenesis both in vitro and in vivo. Furthermore, in breast tumors, SOX4 expression correlates with blood vessel density and size, and predicts poor-prognosis in patients with breast cancer. Our data provide novel mechanistic insights into context-dependent SOX4 target gene selection, and uncover a novel pro-oncogenic role for this transcription factor in promoting tumor-induced angiogenesis. These findings establish a key role for SOX4 in promoting metastasis through exploiting diverse pro-tumorigenic pathways.
DOI: 
http://doi.org/10.7554/eLife.27706
Research group: 
Caldas Group
E-pub date: 
30 Nov 2018
Users with this publication listed: 
Carlos Caldas